Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking with Cabinet colleagues to improve the inclusivity of public services for autistic people.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
From 1 July 2022, service providers registered with the Care Quality Commission (CQC) are required to ensure their staff receive learning disability and autism training appropriate to their role, as set out in the Health and Care Act 2022. To support this, we are rolling out the Oliver McGowan Mandatory Training on Learning Disability and Autism. Over two million people have now completed the e-learning module, which is the first part of the training.
The Government has also committed to raising awareness of all forms of neurodiversity, including autism, in the workplace. An independent panel made of academics with expertise and experiences of neurodiversity, including autism, has been launched to advise the Government on fostering more inclusive workplaces. This will build on the recommendations outlined in the Buckland Review of Autism Employment, which related solely to autism.
The Department of Health and Social Care is also working closely with the Department for Education on reforms to the Special Educational Needs and Disabilities (SEND) system to improve inclusivity and expertise in mainstream schools, as well as ensuring special schools cater to those with the most complex needs. We are also supporting earlier intervention for children with SEND through the Partnerships for Inclusion of Neurodiversity in Schools (PINS) programme. PINS brings together integrated care boards, local authorities, and schools, working in partnership with parents and carers to support schools to better meet the needs of neurodivergent children and their families.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Secretary of State for Education on (a) medical student finance and (b) the adequacy of total financial support during NHS Bursary funded years of study.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department works closely with the Department for Education on a wide range of matters to ensure the education system is supporting healthcare students, including student funding.
For the 2025-26 academic year, the Government will increase the NHS Bursary tuition fee contributions, maintenance grants and all allowances by 3.1%. This is the second consecutive academic year that this Government has increased support through the NHS Bursary. For the 2025-26 academic year, the Government has also announced that maximum loans for living costs from Student Finance England (SFE), including reduced rate non-means tested loans for students in NHS Bursary years, will increase by 3.1%.
The Government reviews the funding arrangements for medical students annually. This includes the NHS Bursary scheme and SFE support.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of transitioning from Student Finance England support to the NHS bursary on the finances of medical students in their final years of study.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department works closely with the Department for Education on a wide range of matters to ensure the education system is supporting healthcare students, including student funding.
For the 2025-26 academic year, the Government will increase the NHS Bursary tuition fee contributions, maintenance grants and all allowances by 3.1%. This is the second consecutive academic year that this Government has increased support through the NHS Bursary. For the 2025-26 academic year, the Government has also announced that maximum loans for living costs from Student Finance England (SFE), including reduced rate non-means tested loans for students in NHS Bursary years, will increase by 3.1%.
The Government reviews the funding arrangements for medical students annually. This includes the NHS Bursary scheme and SFE support.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he has made an assessment of the potential merits of reviewing the effectiveness of the NHS bursary scheme.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department works closely with the Department for Education on a wide range of matters to ensure the education system is supporting healthcare students, including student funding.
For the 2025-26 academic year, the Government will increase the NHS Bursary tuition fee contributions, maintenance grants and all allowances by 3.1%. This is the second consecutive academic year that this Government has increased support through the NHS Bursary. For the 2025-26 academic year, the Government has also announced that maximum loans for living costs from Student Finance England (SFE), including reduced rate non-means tested loans for students in NHS Bursary years, will increase by 3.1%.
The Government reviews the funding arrangements for medical students annually. This includes the NHS Bursary scheme and SFE support.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure all eligible recipients are registered for their NHS Healthy Start entitlement.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The NHS Business Services Authority (NHSBSA) operates the Healthy Start scheme on behalf of the Department. Those eligible for Healthy Start must apply to the NHSBSA to receive Healthy Start payments.
All applicants, where they meet the eligibility criteria, must accept the terms and conditions of the Healthy Start prepaid card at the point of application. As the prepaid card is a financial product and cannot be issued without the applicant accepting these terms, the NHSBSA is not able to automatically provide eligible families with a prepaid card.
We remain open to all viable routes to improve uptake to ensure that as many eligible people as possible are accessing the scheme, to support their children with a healthy start in life.
In March 2025 Healthy Start supported over 359,000 people.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 April 2025 to Question 43451 on Neuroendocrine Cancer: Radiotherapy, what recent discussions his Department has had with Integrated Care Boards on the commissioning of selective internal radiation therapy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England commissions selective internal radiation therapy for chemotherapy refractory / intolerant metastatic colorectal cancer in adults in accordance with criteria which is available at the following link:
The National Cancer Plan, coming later in 2025, will set out plans to improve the experience and outcomes for people at every stage of the cancer pathway. It will include how to improve communication and coordination for patients, so that they feel informed, empowered, and in control of their care.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had discussions with the National Institute for Health and Social Care on providing guidance on the adoption of selective internal radiation therapy for patients with neuroendocrine tumours .
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department has had no such discussions. In May 2024, the National Institute for Health and Care Excellence (NICE) published interventional procedures guidance that recommends that selective internal radiation therapy can be used as an option for neuroendocrine tumours that have metastasised to the liver, with standard arrangements in place for clinical governance, consent, and audit. The NICE’s interventional procedures make recommendations based on an assessment of safety and efficacy, but do not consider whether the procedure represents a clinically and cost-effective use of National Health Service resources. NHS commissioners are responsible for decisions on whether procedures recommended in the NICE’s interventional procedures guidance should be routinely offered to NHS patients.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of selective internal radiation therapy on the (a) survival outcomes and (b) quality of life for neuroendocrine tumour patients.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
No assessment has been made on the potential impact of selective internal radiation therapy (SIRT) on survival outcomes and quality of life for neuroendocrine tumour patients. However, the Department recognises the need to offer suitable treatment, including SIRT, to the patients who need it the most.
Radiotherapy treatment for cancer is highly individualised and decisions about cancer treatment are typically made by clinicians and multidisciplinary teams of healthcare professionals. They consider all aspects of a patient's health and circumstances when recommending treatment options. While certain treatments may not be advised for some patients, these decisions are based on medical assessments and what is best for the individual's overall health and well-being.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential implications for his policies of the report by Kidney Care UK entitled Left Out in the Cold, published on 30 March 2023; and if he will take steps to reduce the variance of home dialysis reimbursement payments made by NHS trusts.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
There are no plans to undertake an assessment of the potential merits of standardising reimbursement for all types of home dialysis, or to reduce variance in payments. Commissioned renal providers in England have a contractual obligation to reimburse the additional utility costs for patients who receive home haemodialysis therapy, as stipulated within the national Haemodialysis to treat established renal failure performed in a patients home service specification and the Paediatric medicine renal service specification, and reimbursement costs are managed directly between providers and patients. Currently, information about patients seeking reimbursement costs is not collected centrally. Further information on the Haemodialysis to treat established renal failure performed in a patients home service specification and the Paediatric medicine renal service specification is available, respectively, at the following two links:
Increasing access to home therapies is a priority for NHS England and this is reflected in its inclusion in the Renal Transformation Toolkit that was published in 2023, which recommends that 20% of all patients on kidney replacement treatment should receive treatment at home.
Commissioned renal clinical networks across England have included improving access to home therapies in their work plans as per the recommendations within the toolkit. The NHS England national team supports renal clinical networks with the implementation of home dialysis transformation.
The renal clinical networks and the renal services clinical reference group are providing input into the Department’s 10-Year Health Plan development process. As part of this, it is highlighted that increasing home dialysis provision will reduce in-centre dialysis demand and this will shift care from a hospital to a community setting. Renal clinical networks are working towards increasing home dialysis rates in line with the Renal Service Transformation Programme Toolkit’s recommendations.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he has made an assessment of the potential merits of standardising reimbursement for all types of home dialysis.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
There are no plans to undertake an assessment of the potential merits of standardising reimbursement for all types of home dialysis, or to reduce variance in payments. Commissioned renal providers in England have a contractual obligation to reimburse the additional utility costs for patients who receive home haemodialysis therapy, as stipulated within the national Haemodialysis to treat established renal failure performed in a patients home service specification and the Paediatric medicine renal service specification, and reimbursement costs are managed directly between providers and patients. Currently, information about patients seeking reimbursement costs is not collected centrally. Further information on the Haemodialysis to treat established renal failure performed in a patients home service specification and the Paediatric medicine renal service specification is available, respectively, at the following two links:
Increasing access to home therapies is a priority for NHS England and this is reflected in its inclusion in the Renal Transformation Toolkit that was published in 2023, which recommends that 20% of all patients on kidney replacement treatment should receive treatment at home.
Commissioned renal clinical networks across England have included improving access to home therapies in their work plans as per the recommendations within the toolkit. The NHS England national team supports renal clinical networks with the implementation of home dialysis transformation.
The renal clinical networks and the renal services clinical reference group are providing input into the Department’s 10-Year Health Plan development process. As part of this, it is highlighted that increasing home dialysis provision will reduce in-centre dialysis demand and this will shift care from a hospital to a community setting. Renal clinical networks are working towards increasing home dialysis rates in line with the Renal Service Transformation Programme Toolkit’s recommendations.